Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Core Natural Resources, Inc.CNR · Entity 3899 | Director | April 30, 2026 | May 01, 2026 |
| Enpro Inc.NPO · Entity 3782 | Director | March 31, 2026 | April 02, 2026 |
| Hayward Holdings, Inc.HAYW · Entity 768 | Director | July 30, 2026 | August 03, 2026 |
| US Ecology, Inc.ECOL · Entity 127674 | Director | May 02, 2022 | May 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Core Natural Resources, Inc.
Report date April 30, 2026 · Filed May 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per share ("Common Stock")SEC Table I · non-derivative | Direct | 1,390 |
Reported balance
After 2026-04-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-30 · Grant · Acquired 1,390 · Balance 1,390 F1: Represents a grant of restricted stock units pursuant to the Issuer's Omnibus Performance Incentive Plan, which vest on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2: Of the 1,390 shares reported, 1,390 are unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units pursuant to the Issuer's Omnibus Performance Incentive Plan, which vest on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2: Of the 1,390 shares reported, 1,390 are unvested restricted stock units.
Enpro Inc.
Report date March 31, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 4,289.2459 |
Reported balance
After 2026-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-31 · Grant · Acquired 99.7407 · Balance 4,289.2459 F1: 1-for-1 F2: Share units acquired under the Deferred Compensation Plan for Non-Employee Directors (as amended and restated) of EnPro Industries, Inc. F3: Upon retirement F4: These shares do not have an expiration date and they are exercisable upon retirement |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Share units acquired under the Deferred Compensation Plan for Non-Employee Directors (as amended and restated) of EnPro Industries, Inc.
F3: Upon retirement
F4: These shares do not have an expiration date and they are exercisable upon retirement
Hayward Holdings, Inc.
Report date July 30, 2026 · Filed August 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 60,672 |
Reported balance
After 2026-07-30 transaction · row 1
1 source rowRow 1 · 2026-07-30 · Grant · Acquired 1,501 · Balance 60,672 F1: Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The restricted stock units vest on December 31, 2026, provided that the Reporting Person remains in continuous service with the Issuer through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The restricted stock units vest on December 31, 2026, provided that the Reporting Person remains in continuous service with the Issuer through the vesting date.
US Ecology, Inc.
Report date May 02, 2022 · Filed May 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-02 transaction · row 1
1 source rowRow 1 · 2022-05-02 · Disposition to issuer · Disposed 9,800 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. ("Parent") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest ("Merger Consideration"). |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. ("Parent") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest ("Merger Consideration").
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Evoqua Water Technologies Corp.
Report date May 24, 2023 · Filed May 26, 2023
Section 16 reporting ended · disclosed 2023-05-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-05-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-05-24 · Grant · Acquired 249,362 · Balance 1,093,399 F1: Represents performance share units ("PSUs") that became earned (at target award level) pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023, upon effectiveness of the merger on May 24, 2023. Row 2 · 2023-05-24 · Disposition to issuer · Disposed 1,093,399 · Balance 0 F2: Disposed of pursuant to the merger agreement. Upon effectiveness of the merger, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") and PSUs (at target award level) were converted into RSUs relating to Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.64 · Expires 2024-12-15 | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-05-24 · Disposition to issuer · Disposed 1,000,000 · Balance 0 F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F3: This option is fully vested. F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.42 · Expires 2026-10-28 | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-05-24 · Disposition to issuer · Disposed 29,653 · Balance 0 F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F3: This option is fully vested. F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.88 · Expires 2028-04-02 | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-05-24 · Disposition to issuer · Disposed 294,864 · Balance 0 F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F3: This option is fully vested. F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.67 · Expires 2029-02-14 | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-05-24 · Disposition to issuer · Disposed 304,935 · Balance 0 F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F3: This option is fully vested. F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.63 · Expires 2030-02-14 | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-05-24 · Disposition to issuer · Disposed 252,684 · Balance 0 F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. F6: This option vests in four equal annual installments starting on Jan. 1, 2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.76 · Expires 2031-02-16 | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-05-24 · Disposition to issuer · Disposed 192,693 · Balance 0 F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. F7: This option vests in four equal annual installments starting on Feb. 16, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents performance share units ("PSUs") that became earned (at target award level) pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023, upon effectiveness of the merger on May 24, 2023.
F2: Disposed of pursuant to the merger agreement. Upon effectiveness of the merger, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") and PSUs (at target award level) were converted into RSUs relating to Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share.
F3: This option is fully vested.
F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share.
F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent.
F6: This option vests in four equal annual installments starting on Jan. 1, 2021.
F7: This option vests in four equal annual installments starting on Feb. 16, 2022.
US Ecology Holdings, Inc.
Report date November 01, 2019 · Filed November 01, 2019
Section 16 reporting ended · disclosed 2019-11-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-11-01 transaction · row 1
1 source rowRow 1 · 2019-11-01 · Disposition to issuer · Disposed 3,800 · Balance 0 F1: Disposed pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) ("Parent"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) ("Holdco"), ECOL Merger Sub, Inc. ("ECOL Merger Sub") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) ("Parent"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) ("Holdco"), ECOL Merger Sub, Inc. ("ECOL Merger Sub") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 08, 2022 Filed Aug 9, 2022 20:44 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionStock Option (Right to Buy) · Derivative | 78,159 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001604643-22-000120 · wf-form4_166007787199161.xml · derivative · entry 6 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 78,159 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 20:44 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 78,159 | $38.61 | $3,017,531.41 |
DisclosureSEC source: 0001604643-22-000120 · wf-form4_166007787199161.xml · nonDerivative · entry 4 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 762,724 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.3200 to $38.7750, inclusive. F1 · balance_after: The amount of these securities includes an aggregate of 336,323 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 20:44 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionCommon Stock | 78,159 | $4.64 | $362,657.76 |
DisclosureSEC source: 0001604643-22-000120 · wf-form4_166007787199161.xml · nonDerivative · entry 3 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount of these securities includes an aggregate of 336,323 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:44 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionStock Option (Right to Buy) · Derivative | 165,422 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001604643-22-000120 · wf-form4_166007787199161.xml · derivative · entry 5 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,159 Underlying: Common Stock · 165,422 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:44 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 165,422 | $38.77 | $6,413,923.75 |
DisclosureSEC source: 0001604643-22-000120 · wf-form4_166007787199161.xml · nonDerivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 762,724 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.6000 to $39.0350, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4. F1 · balance_after: The amount of these securities includes an aggregate of 336,323 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:44 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionCommon Stock | 165,422 | $4.64 | $767,558.08 |
DisclosureSEC source: 0001604643-22-000120 · wf-form4_166007787199161.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 928,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount of these securities includes an aggregate of 336,323 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| May 21, 2022 Filed May 24, 2022 21:19 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 82,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001604643-22-000111 · wf-form4_165342717140702.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 762,724 F1 · shares: Represents the number of performance share units earned under the performance share unit award granted on May 18, 2021, upon certification by the Compensation Committee of the issuer's performance results for the one-year performance period ended May 18, 2022. The earned performance share units will settle at the end of the final performance period under the award on May 18, 2024, subject to the reporting person's continued employment with the issuer. F2 · balance_after: The amount of these securities includes an aggregate of 336,323 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| May 18, 2022 Filed May 20, 2022 21:10 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 23,225 | $36.35 | $844,228.75 |
DisclosureSEC source: 0001604643-22-000095 · wf-form4_165308103413570.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 680,709 F1 · balance_after: The amount of these securities includes 254,308 unvested restricted stock units in respect of the issuer's common stock. Read SEC document |
| May 02, 2022 Filed May 3, 2022 16:30 UTC | US Ecology, Inc. ECOL · Entity 127674 | Disposition to issuerCommon Stock | 9,800 | $48.00 | $470,400.00 |
DisclosureSEC source: 0001437749-22-010684 · rdgdoc.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. ("Parent") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest ("Merger Consideration"). F1 · shares: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. ("Parent") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest ("Merger Consideration"). Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 22:40 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 7,410 | $43.98 | $325,891.80 |
DisclosureSEC source: 0001604643-22-000042 · wf-form4_164513761093349.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703,934 F1 · balance_after: The amount of these securities includes 308,979 unvested restricted stock units in respect of the issuer's common stock. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 21:55 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 13,642 | $46.75 | $637,763.50 |
DisclosureSEC source: 0001604643-22-000020 · wf-form4_164133332027740.xml · nonDerivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 711,344 F2 · balance_after: The amount of these securities includes 326,446 unvested restricted stock units in respect of the issuer's common stock. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:55 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 37,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001604643-22-000020 · wf-form4_164133332027740.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724,986 F1 · kind: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, these restricted stock units are scheduled to vest in equal installments on each of January 1, 2023, January 1, 2024, and January 1, 2025, and settle within 30 days of the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 13:07 UTC | US Ecology, Inc. ECOL · Entity 127674 | GrantCommon Stock | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-013682 · rdgdoc.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,800 F1 · price: Restricted stock issued pursuant to US Ecology, Inc.'s director compensation program and the Amended and Restated US Ecology, Inc. Omnibus Incentive Plan. Read SEC document |
| May 18, 2021 Filed May 19, 2021 21:49 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 164,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001604643-21-000042 · wf-form4_162146094980498.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687,981 F1 · kind: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, these restricted stock units are scheduled to vest in equal installments on each of May 18, 2022, May 18, 2023, and May 18, 2024, and settle within 30 days of the applicable vesting date. F2 · balance_after: The amount of these securities includes 328,793 unvested restricted stock units in respect of the issuer's common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:35 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantStock Option (Right to Buy) · Derivative | 192,693 | $0.00 Strike: $24.76 | $0.00 |
DisclosureSEC source: 0001246360-21-000482 · form.xml · derivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,693 Underlying: Common Stock · 192,693 shares Expires 2031-02-16 F3 · derivative.exercise_date: Subject to the reporting person's continued employment through the applicable vesting date, this option is scheduled to vest in equal installments on each of February 16, 2022, January 1, 2023, January 1, 2024 and January 1, 2025. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:35 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 69,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000482 · form.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,950 F1 · security: The amount of these securities shown in column 5 of this table includes 164,762 unvested restricted stock units in respect of the issuer's common stock. F2 · kind: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, these restricted stock units are scheduled to vest in equal installments on each of February 16, 2022, January 1, 2023, January 1, 2024 and January 1, 2025, and settle within 30 days of the applicable vesting date. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 22:56 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001246360-21-000068 · form.xml · derivative · entry 4 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,243,581 Underlying: Common Stock · 400,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Keating on December 7, 2020. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 22:56 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 8,976 | $30.20 | $271,068.02 |
DisclosureSEC source: 0001246360-21-000068 · form.xml · nonDerivative · entry 3 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,079 F1 · security: The amount of these securities shown in column 5 of this table includes 94,891 unvested restricted stock units in respect of the issuer's common stock. Subject to Mr. Keating's continued employment with the issuer through the applicable vesting date, 46,330 of these restricted stock units are scheduled to vest in equal installments on each of January 1, 2022 and January 1, 2023 and settle within 30 days of the applicable vesting date; and 48,561 of these restricted stock units are scheduled to vest in equal installments on each of January 1, 2022, January 1, 2023 and January 1, 2024 and settle within 30 days of the applicable vesting date. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Keating on December 7, 2020. F5 · price: The price reported in column 4 of this table is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.1200 to $30.2600, inclusive. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 22:56 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 391,024 | $29.56 | $11,560,350.84 |
DisclosureSEC source: 0001246360-21-000068 · form.xml · nonDerivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,055 F1 · security: The amount of these securities shown in column 5 of this table includes 94,891 unvested restricted stock units in respect of the issuer's common stock. Subject to Mr. Keating's continued employment with the issuer through the applicable vesting date, 46,330 of these restricted stock units are scheduled to vest in equal installments on each of January 1, 2022 and January 1, 2023 and settle within 30 days of the applicable vesting date; and 48,561 of these restricted stock units are scheduled to vest in equal installments on each of January 1, 2022, January 1, 2023 and January 1, 2024 and settle within 30 days of the applicable vesting date. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Keating on December 7, 2020. F4 · price: The price reported in column 4 of this table is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.1200 to $30.1150, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 and 5 to this Form 4. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 22:56 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionCommon Stock | 400,000 | $4.64 | $1,856,000.00 |
DisclosureSEC source: 0001246360-21-000068 · form.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 854,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The amount of these securities shown in column 5 of this table includes 94,891 unvested restricted stock units in respect of the issuer's common stock. Subject to Mr. Keating's continued employment with the issuer through the applicable vesting date, 46,330 of these restricted stock units are scheduled to vest in equal installments on each of January 1, 2022 and January 1, 2023 and settle within 30 days of the applicable vesting date; and 48,561 of these restricted stock units are scheduled to vest in equal installments on each of January 1, 2022, January 1, 2023 and January 1, 2024 and settle within 30 days of the applicable vesting date. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Keating on December 7, 2020. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 01:35 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 11,396 | $26.98 | $307,464.08 |
DisclosureSEC source: 0001246360-21-000043 · form.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,079 F1 · security: The amount of these securities shown in column 5 of this table includes 94,891 unvested restricted stock units in respect of the issuer's common stock. Subject to Mr. Keating's continued employment with the issuer through the applicable vesting date, 46,330 of these restricted stock units are scheduled to vest in equal installments on each of January 1, 2022 and January 1, 2023 and settle within 30 days of the applicable vesting date; and 48,561 of these restricted stock units are scheduled to vest in equal installments on each of January 1, 2022, January 1, 2023 and January 1, 2024 and settle within 30 days of the applicable vesting date. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 22:14 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionStock Option (Right to Buy) · Derivative | 399,793 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001246360-20-001607 · form.xml · derivative · entry 6 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643,581 Underlying: Common Stock · 399,793 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Keating on May 12, 2020. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 22:14 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 399,793 | $22.07 | $8,821,432.55 |
DisclosureSEC source: 0001246360-20-001607 · form.xml · nonDerivative · entry 4 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,475 F1 · security: The amount of these securities shown in column 5 of this table includes 134,243 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by Mr. Keating on February 19, 2020. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Keating on May 12, 2020. F4 · price: The price reported in column 4 of this table is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.1850, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 22:14 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionCommon Stock | 399,793 | $4.64 | $1,855,039.52 |
DisclosureSEC source: 0001246360-20-001607 · form.xml · nonDerivative · entry 3 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The amount of these securities shown in column 5 of this table includes 134,243 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by Mr. Keating on February 19, 2020. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Keating on May 12, 2020. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 22:14 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,095 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001246360-20-001607 · form.xml · derivative · entry 5 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,043,374 Underlying: Common Stock · 6,095 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Keating on May 12, 2020. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 22:14 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 6,095 | $22.00 | $134,090.00 |
DisclosureSEC source: 0001246360-20-001607 · form.xml · nonDerivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,475 F1 · security: The amount of these securities shown in column 5 of this table includes 134,243 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by Mr. Keating on February 19, 2020. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Keating on May 12, 2020. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 22:14 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionCommon Stock | 6,095 | $4.64 | $28,280.80 |
DisclosureSEC source: 0001246360-20-001607 · form.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The amount of these securities shown in column 5 of this table includes 134,243 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by Mr. Keating on February 19, 2020. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Keating on May 12, 2020. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 21:10 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,112 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001604643-20-000028 · primary_doc.xml · derivative · entry 3 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,049,469 Underlying: Common Stock · 14,112 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 21:10 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 14,112 | $22.00 | $310,464.00 |
DisclosureSEC source: 0001604643-20-000028 · primary_doc.xml · nonDerivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,475 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020. F2 · balance_after: This amount includes 134,243 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by the reporting person on February 19, 2020. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 21:10 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionCommon Stock | 14,112 | $4.64 | $65,479.68 |
DisclosureSEC source: 0001604643-20-000028 · primary_doc.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020. F2 · balance_after: This amount includes 134,243 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by the reporting person on February 19, 2020. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 14:32 UTC | US Ecology, Inc. ECOL · Entity 127674 | GrantCommon Stock | 3,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-012599 · rdgdoc.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,900 F1 · price: Restricted stock issued pursuant to US Ecology, Inc.'s director compensation program and Amended and Restated Omnibus Incentive Plan. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 00:48 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantStock Option (Right to Buy) · Derivative | 252,684 | $0.00 Strike: $23.63 | $0.00 |
DisclosureSEC source: 0000895345-20-000226 · form4.xml · derivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,684 Underlying: Common Stock · 252,684 shares Expires 2030-02-14 F3 · derivative.exercise_date: Subject to the reporting person's continued employment with the issuer through the applicable vesting date, this option is scheduled to vest in equal installments on each of January 1, 2021, January 1, 2022, January 1, 2023 and January 1, 2024. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 00:48 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 64,748 | $0.00 | $0.00 |
DisclosureSEC source: 0000895345-20-000226 · form4.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,475 F1 · kind: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, these restricted stock units are scheduled to vest in equal installments on each of January 1, 2021, January 1, 2022, January 1, 2023 and January 1, 2024 and settle within 30 days of the applicable vesting date. F2 · balance_after: This amount includes 134,243 unvested restricted stock units in respect of the issuer's common stock. Of these restricted stock units, 64,748 are scheduled to vest as described in footnote 1 to this Form 4 and 69,495 are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of January 1, 2021, January 1, 2022 and January 1, 2023 and settle within 30 days of the applicable vesting date. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 21:10 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 6,708 | $18.95 | $127,116.60 |
DisclosureSEC source: 0001567619-20-000316 · doc1.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,727 F1 · balance_after: This amount includes 69,495 unvested restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, these restricted stock units are scheduled to vest in equal installments on each of January 1, 2021, January 1, 2022 and January 1, 2023 and settle within 30 days of the applicable vesting date. Read SEC document |
| November 02, 2019 Filed Nov 5, 2019 21:08 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 174,700 | $17.69 | $3,090,443.00 |
DisclosureSEC source: 0001567619-19-020433 · doc1.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,435 F1 · balance_after: This amount includes 92,660 unvested restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, these restricted stock units are scheduled to vest in equal installments on each of January 1, 2020, January 1, 2021, January 1, 2022 and January 1, 2023 and settle within 30 days of the applicable vesting date. Read SEC document |
| November 01, 2019 Filed Nov 1, 2019 09:40 UTC | US Ecology Holdings, Inc. ECOL · Entity 154125 | Disposition to issuerCommon Stock | 3,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-19-021154 · rdgdoc.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) ("Parent"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) ("Holdco"), ECOL Merger Sub, Inc. ("ECOL Merger Sub") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco. Read SEC document |
| November 01, 2019 Filed Nov 1, 2019 12:39 UTC | US Ecology, Inc. ECOL · Entity 127674 | GrantCommon Stock | 3,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-19-021236 · rdgdoc.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 F1 · price: Acquired pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) ("Parent"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) ("Holdco"), ECOL Merger Sub, Inc. ("ECOL Merger Sub") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco. Read SEC document |
| May 22, 2019 Filed May 23, 2019 16:14 UTC | US Ecology Holdings, Inc. ECOL · Entity 154125 | GrantCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-010753 · rdgdoc.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 F1 · price: Restricted stock issued pursuant to US Ecology, Inc.'s director compensation program and Omnibus Incentive Plan. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:38 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantStock Option (Right to Buy) · Derivative | 304,935 | $0.00 Strike: $12.67 | $0.00 |
DisclosureSEC source: 0001567619-19-004908 · doc1.xml · derivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,935 Underlying: Common Stock · 304,935 shares Expires 2029-02-14 F3 · derivative.exercise_date: Subject to the reporting person's continued employment with the issuer through the applicable vesting date, this option is scheduled to vest in equal installments on each of January 1, 2020, January 1, 2021, January 1, 2022 and January 1, 2023. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:38 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 92,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-004908 · doc1.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,135 F1 · kind: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, these restricted stock units are scheduled to vest in equal installments on each of January 1, 2020, January 1, 2021, January 1, 2022 and January 1, 2023 and settle within 30 days of the applicable vesting date. F2 · balance_after: This amount includes 523,695 unvested restricted stock units in respect of the issuer's common stock. Of these restricted stock units, 92,660 are scheduled to vest as described in footnote 1 to this Form 4 and 431,035 are scheduled to vest as described in the Form 4 filed by the reporting person on November 6, 2017. Read SEC document |
| December 03, 2018 Filed Dec 3, 2018 23:00 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | PurchaseCommon Stock | 30,182 | $9.37 | $282,811.38 |
DisclosureSEC source: 0001567619-18-007270 · doc1.xml · nonDerivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,475 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.31 to $9.40, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: This amount includes 431,035 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by the reporting person on November 6, 2017. Read SEC document |
| November 30, 2018 Filed Dec 3, 2018 23:00 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | PurchaseCommon Stock | 24,236 | $8.99 | $217,976.16 |
DisclosureSEC source: 0001567619-18-007270 · doc1.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,293 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.75 to $9.00, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: This amount includes 431,035 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by the reporting person on November 6, 2017. Read SEC document |
| May 23, 2018 Filed May 29, 2018 08:48 UTC | US Ecology Holdings, Inc. ECOL · Entity 154125 | GrantCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010787 · rdgdoc.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · price: Restricted stock issued pursuant to US Ecology, Inc.'s director compensation program and Omnibus Incentive Plan. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 23:20 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantStock Option (Right to Buy) · Derivative | 294,864 | $0.00 Strike: $20.88 | $0.00 |
DisclosureSEC source: 0001140361-18-017212 · doc1.xml · derivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,864 Underlying: Common Stock · 294,864 shares Expires 2028-04-02 F1 · derivative.exercise_date: Subject to the reporting person's continued employment with the issuer through the applicable vesting date, this option is scheduled to vest in equal installments on each of January 1, 2019, January 1, 2020, January 1, 2021 and January 1, 2022. Read SEC document |
| March 21, 2018 Filed Mar 21, 2018 22:15 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 44,122 | $21.29 | $939,136.77 |
DisclosureSEC source: 0001140361-18-014513 · doc1.xml · nonDerivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,057 F2 · shares: These shares of common stock were sold pursuant to the Underwriting Agreement dated March 14, 2018. F3 · price: This amount represents the $22.00 public offering price per share of the issuer's common stock less the underwriting discount of $0.715 per share. F4 · balance_after: This amount includes 431,035 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by the reporting person on November 6, 2017. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 22:15 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 294,149 | $21.29 | $6,260,961.47 |
DisclosureSEC source: 0001140361-18-014513 · doc1.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,179 F1 · kind: This sale of shares of the issuer's common stock was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 3,000 shares, with the purchase by the reporting person of 3,000 shares of the issuer's common stock at a price of $18.00 per share on November 6, 2017 as part of a directed share program in connection with the issuer's initial public offering. The reporting person has agreed to pay to the issuer $9,855.00, representing the full amount of the profit realized in connection with the short-swing transaction, less the underwriting discount of $0.715 per share. F2 · shares: These shares of common stock were sold pursuant to the Underwriting Agreement dated March 14, 2018. F3 · price: This amount represents the $22.00 public offering price per share of the issuer's common stock less the underwriting discount of $0.715 per share. F4 · balance_after: This amount includes 431,035 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by the reporting person on November 6, 2017. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:33 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionStock Option (Right to Buy) · Derivative | 430,000 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001140361-18-013907 · doc1.xml · derivative · entry 3 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063,581 Underlying: Common Stock · 430,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is vested with respect to 1,870,185 underlying shares (including the 430,000 shares underlying the portion of the stock option being exercised) and will vest with respect to the remaining 623,396 underlying shares on December 15, 2018. F2 · balance_after: This option is vested with respect to 1,870,185 underlying shares (including the 430,000 shares underlying the portion of the stock option being exercised) and will vest with respect to the remaining 623,396 underlying shares on December 15, 2018. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:33 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 228,732 | $23.40 | $5,352,328.80 |
DisclosureSEC source: 0001140361-18-013907 · doc1.xml · nonDerivative · entry 2 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 773,328 F1 · balance_after: This amount includes 431,035 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by the reporting person on November 6, 2017. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:33 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionCommon Stock | 430,000 | $4.64 | $1,995,200.00 |
DisclosureSEC source: 0001140361-18-013907 · doc1.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,002,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This amount includes 431,035 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by the reporting person on November 6, 2017. Read SEC document |
| November 06, 2017 Filed Nov 9, 2017 01:08 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | PurchaseCommon Stock | 3,000 | $18.00 | $54,000.00 |
DisclosureSEC source: 0001140361-17-041656 · doc1.xml · nonDerivative · entry 1 Keating Ronald C · CIK 0001353838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572,060 F1 · shares: The reporting person purchased these shares in connection with the closing of the initial public offering of the issuer (the "IPO") at the IPO price of $18.00 per share pursuant to the directed share program described in the issuer's registration statement. The shares are subject to a lock-up provision for a period of 180 days, as required under a lock-up agreement with the underwriters of the IPO. F2 · balance_after: This amount includes 431,035 unvested restricted stock units in respect of the issuer's common stock. These restricted stock units are scheduled to vest as described in the Form 4 filed by the reporting person on November 6, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.